Importantly, our analysis confirmed the previously published negative impact of PFKFB4 on the prognosis of glioma patients [23] and negative impact of PFKFB3 on the prognosis of hepatocellular cancer [24]. This evidence concerns the gene PFKFB4 and central nervous system cancer.